Radioligand Therapy in Meningiomas: Today's Evidence, Tomorrow's Possibilities. [PDF]
Sipka G +12 more
europepmc +1 more source
Prognostic implications of [¹⁸F]FDG PET and metabolic changes in patients with advanced metastatic neuroendocrine tumors undergoing rechallenge PRRT: final results from a multicenter 10-year survival WARMTH study. [PDF]
Santo G +9 more
europepmc +1 more source
Renal function affects absorbed dose to the kidneys and haematological toxicity during Lu-DOTATATE treatment [PDF]
core +1 more source
Management of Peptide Receptor Radionuclide Therapy Toxicities in Neuroendocrine Neoplasm Patients. [PDF]
Mohindroo C, Ramirez RA.
europepmc +1 more source
Paving the Way for CCK2R-Targeted Peptide Receptor Radionuclide Therapy with [<sup>177</sup>Lu]Lu-DOTA-MGS5 in Patients with Small Cell Lung Cancer. [PDF]
Zavvar TS +13 more
europepmc +1 more source
Somatostatin receptor PET-guided treatment and artificial intelligence applications in meningioma: a comprehensive review. [PDF]
Gujral J +7 more
europepmc +1 more source
The SCARLET Trial: Radiotheranostics in Multiple Myeloma. [PDF]
Jain S, Graham MM.
europepmc +1 more source
Efficacy and Safety of Non-Surgical Treatments for Pancreatic Neuroendocrine Tumors: A Systematic Review and Meta-Analysis. [PDF]
AlQahtani MS +5 more
europepmc +1 more source
Intra-Arterial Radioligand Therapy in Brain Cancer: Bridging Nuclear Medicine and Interventional Neuroradiology. [PDF]
Sabuzi F +5 more
europepmc +1 more source

